| 210. PCO-1097 | Use of a Patient Self-Screening Tool and Patient Alert Card to Identify and Manage Severe Adverse Drug Reactions นฤมล เจริญศิริพรกุล (2023-06-22) | 1017 |  |  |  |  |  |  |  |  |  | |
| 211. PCO-1096 | Practices of community pharmacists on COVID-19 pandemic, barriers, and views on providing pharmacy services in Thailand นฤมล เจริญศิริพรกุล (2023-06-22) | 1017 |  |  |  |  |  |  |  |  |  | |
| 212. PCO-1095 | Cymbopogon citratus L. essential oil as a potential anti-biofilm agent against antibiotic-resistant bacteria isolated from chronic rhinosinusitis patients สกาวรัตน์ กันทะวงศ์ (2023-06-19) | 1020 |  |  |  |  |  |  |  |  |  | |
| 213. PCO-1093 | Biomarkers for Prognosis of Meningioma Patients: Systematic Review and
Meta-analysis Siriporn Proungvitaya (2023-06-15) | 1024 |  |  |  | | | | | | | |
| 214. PCO-1092 | Comparison of outcomes between total en bloc spondylectomy and palliative spinal surgery in metastatic spinal tumor patients: propensity score matching analysis เพิ่มศักดิ์ พหลภาคย์ (2023-06-14) | 1025 |  |  |  | | | | | | | |
| 215. PCO-1090 | The current situation with therapeutic drug monitoring in Thailand: Requirements, challenges and the role of educational institutions ศิริลักษณ์ ใจซื่อ (2023-06-13) | 1026 |  |  |  | | | | | | | |
| 216. PCO-1089 | Anti-cancer activities and metabolic profiling of Benjakul and herbal components in cholangiocarcinoma Anchalee Techasen (2023-06-12) | 1027 |  |  |  | | | | | | | |
| 217. PCO-1088 | CDKN3 acts as a tumor promoter in promoting proliferation of cholangiocarcinoma cells วรฉัตร เลิศอิทธิพร (2023-06-02) | 1037 |  |  |  | | | | | | | |
| 218. PCO-1087 | Mortality rate and factors associated with mortality of carbapenems-resistant Enterobacteriaceae infection อภิชาติ โซ่เงิน (2023-06-01) | 1038 |  |  |  |  |  |  |  |  |  | |
| 219. PCO-1086 | Improved antibody immobilization for Opisthorchis viverrini (Ov) antigen detection in urine samples by a combining approach method: APTES and EDC-NHS coupling solution watcharin loilome (2023-05-27) | 1043 |  |  |  | | | | | | | |
| 220. PCO-1085 | Evaluation of Anti-Inflammatory Effects of a Thai Traditional Polyherbal Recipe TPDM6315 in LPS-induced Macrophages (RAW 264.7) and TNF-α induced 3T3-L1 Adipocytes นาฏศจี นวลแก้ว (2023-05-25) | 1045 |  |  |  |  |  |  |  |  |  | |
| 221. PCO-1084 | Cobalt-ZIF materials with different structure and morphology synthesized by water-based synthesis method for catalyzing NaBH4 hydrolysis reaction กิ่งแก้ว ฉายากุล ชนาภัทรภณ (2023-05-23) | 1047 |  |  |  |  |  |  |  |  |  | |
| 222. PCO-1083 | Effects of COVID-19 vaccines on male fertility: a systematic review and meta-analysis Nantasiri Eamudomkarn (2023-05-22) | 1048 |  |  |  | | | | | | | |
| 223. PCO-1082 | Octanoyl-sulfated galactans promotes cellular uptake and activates type I collagen expression through mediating the phosphorylation of Smad proteins in fibroblasts ทวุธ รัตนทิพย์ (2023-05-19) | 1051 |  |  |  |  |  |  |  |  |  | |
| 224. PCO-1081 | Burkholderia pseudomallei biofilm persisted Acanthamoeba sp. grazing and produced 8-O-4´-diferulic acid, a superoxide scavenging metabolite after repeat-encountered with the amoeba โสรัจสิริ เจริญสุดใจ (2023-05-15) | 1055 |  |  |  |  |  |  |  |  |  | |
| 225. PCO-1079 | Dienogest versus combined oral contraceptive pill as a treatment of endometriosis-associated pelvic pain: a systematic review and meta-analysis woraluk somboonporn (2023-05-12) | 1058 |  |  |  | | | | | | | |
| 226. PCO-1078 | Association of Wisteria floribunda agglutinin binding LacdiNAc-associated glycans with carcinogenesis and metastasis of cholangiocarcinoma อาทิตย์ ศิลป์ศิริวานิชย์ (2023-05-07) | 1063 |  |  |  |  |  |  |  |  |  | |
| 227. PCO-1077 | Melatonin attenuates Helicobacter pylori-mediated cholangiocarcinoma-associated fibroblast activation via modulating integrin/FAK signaling pathway สมชาย ปิ่นละออ (2023-05-02) | 1068 |  |  |  | | | | | | | |
| 228. PCO-1076 | Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions นนทญา นาคคำ (2023-04-30) | 1070 |  |  |  |  |  |  |  |  |  | |
| 229. PCO-1074 | Phenotypic drug susceptibility profiles and genetic analysis based on whole genome sequencing of Mycobacterium avium complex isolates in Thailand เกียรติไชย ฟักศรี (2023-04-22) | 1078 |  |  |  | | | | | | | |
| 230. PCO-1073 | Immunoglobulin G level against SAR-CoV-2 in Thai systemic sclerosis patients: a case control study of National Health Thailand program for SAR-CoV-2 vaccine Chingching Foocharoen (2023-04-12) | 1088 |  |  |  | | | | | | | |
| 231. PCO-1072 | Thailand experience on advance care planning Srivieng Pairojkul, MD. (2023-04-02) | 1098 |  |  |  | | | | | | | |
| 232. PCO-1071 | Development and optimization of tensile strength prediction model of compacted ribbons using NIR-HIS analysis จอมใจ สัจจะอารีวัฒน์ (2023-03-29) | 1102 |  |  |  | | | | | | | |
| 233. PCO-1070 | How Patients Identify, Manage and Prevent Severe Adverse Drug Reactions นฤมล เจริญศิริพรกุล (2023-03-28) | 1103 |  |  |  |  |  |  |  |  |  | |
| 234. PCO-1069 | Cannabidiol suppresses proliferation and induces cell death, autophagy and senescence in human cholangiocarcinoma cells via the PI3K/AKT/mTOR pathway พรทิพย์ ปิ่นละออ (2023-03-23) | 1108 |  |  |  | | | | | | | |
| 235. PCO-1068 | Helicobacter pylori extract induces neutrophils to produce reactive oxygen species only in the presence of plasma คณิน ซาเหลา (2023-03-21) | 1110 |  |  |  | | | | | | | |
| 236. PCO-1067 | Tiliacorinine induces apoptotic cell death in cholangiocarcinoma cells by co-targeting EGFR, its downstream signaling โสพิศ วงศ์คำ (2023-03-17) | 1114 |  |  |  | | | | | | | |
| 237. PCO-1066 | Alteration of STK11 expression associated with cholangiocarcinoma progression Anchalee Techasen (2023-03-13) | 1118 |  |  |  |  |  |  |  |  |  | |
| 238. PCO-1065 | Pesticide exposure and risk of Cholangiocarcinoma: A hospital-based matched case-control study สุพจน์ คำสะอาด (2023-03-06) | 1125 |  |  |  |  |  |  |  |  |  | |
| 239. PCO-1064 | Factors Affecting to Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormality Pap Smear: Results from the CCS Program Mr.Supot Kamsa-ard (2023-03-03) | 1128 |  |  |  | | | | | | | |